The new center will design novel drug-like molecules using generative AI and optimize existing compounds to enhance their ...

Details of the presentation are as follows: Arrakis’s DM1 drug program represents a rationally designed small molecule genetic medicine directed at a pathogenic RNA to achieve reversal of ...

Drug delivery technologies designed to protect and control the biodistribution of the active biologic or small molecule are ... protein biologics, gene therapy and RNA medicine represent the ...

Adding immunotherapy to a new type of inhibitor that targets multiple forms of the cancer-causing gene mutation KRAS ... showed that a small molecule inhibitor specifically targeting KRAS G12D ...

To achieve this, the researchers designed a small ribozyme-based RNA molecule ... between mobile genetic elements." The RAM method has possible far-reaching applications in medicine, biotechnology ...

The AI Small Molecule Drug Discovery Center ... Charles Bronfman Institute for Personalized Medicine. "By integrating artificial intelligence with genetic insights, we can move beyond conventional ...

The Icahn School of Medicine at Mount Sinai has launched the AI Small Molecule Drug Discovery Center, a bold endeavor that harnesses artificial intelligence (AI) to revolutionize drug development.